Mirae Asset Global Investments’s Phathom Pharmaceuticals PHAT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25.9K | Buy |
2,697
+409
| +18% | +$3.92K | ﹤0.01% | 1359 |
|
|
2025
Q1 | $15.1K | Buy |
2,288
+9
| +0.4% | +$59 | ﹤0.01% | 1419 |
|
|
2024
Q4 | $18.6K | Sell |
2,279
-191
| -8% | -$1.56K | ﹤0.01% | 1431 |
|
|
2024
Q3 | $43.3K | Buy |
2,470
+722
| +41% | +$12.6K | ﹤0.01% | 1328 |
|
|
2024
Q2 | $18.2K | Sell |
1,748
-12,158
| -87% | -$126K | ﹤0.01% | 1394 |
|
|
2024
Q1 | $102K | Buy |
13,906
+270
| +2% | +$1.97K | ﹤0.01% | 2369 |
|
|
2023
Q4 | $124K | Buy |
13,636
+95
| +0.7% | +$867 | ﹤0.01% | 2425 |
|
|
2023
Q3 | $140K | Buy |
13,541
+97
| +0.7% | +$1.01K | ﹤0.01% | 2385 |
|
|
2023
Q2 | $193K | Buy |
13,444
+210
| +2% | +$3.01K | ﹤0.01% | 2352 |
|
|
2023
Q1 | $94.5K | Sell |
13,234
-26
| -0.2% | -$186 | ﹤0.01% | 2456 |
|
|
2022
Q4 | $149K | Buy |
+13,260
| New | +$149K | ﹤0.01% | 2370 |
|
|
2022
Q3 | – | Sell |
-89,942
| Closed | -$6.7M | – | 2649 |
|
|
2022
Q2 | $6.7M | Buy |
+89,942
| New | +$6.7M | 0.02% | 741 |
|